GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carmat (STU:CXT) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Carmat (STU:CXT) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jul. 19, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Carmat Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Carmat's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Carmat's Future 3-5Y EPS without NRI Growth Rate

For the Medical Devices subindustry, Carmat's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carmat's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carmat's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Carmat's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Carmat  (STU:CXT) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Carmat Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Carmat's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Carmat Business Description

Industry
Traded in Other Exchanges
Address
36, avenue de l’Europe, Immeuble l’Etendard Energy III, Velizy Villacoublay, FRA, 78140
Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.